1. Home
  2. SONM vs PMCB Comparison

SONM vs PMCB Comparison

Compare SONM & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • PMCB
  • Stock Information
  • Founded
  • SONM 1999
  • PMCB 1996
  • Country
  • SONM United States
  • PMCB United States
  • Employees
  • SONM N/A
  • PMCB N/A
  • Industry
  • SONM Telecommunications Equipment
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SONM Telecommunications
  • PMCB Health Care
  • Exchange
  • SONM Nasdaq
  • PMCB Nasdaq
  • Market Cap
  • SONM 15.0M
  • PMCB 15.8M
  • IPO Year
  • SONM 2019
  • PMCB N/A
  • Fundamental
  • Price
  • SONM $2.93
  • PMCB $1.77
  • Analyst Decision
  • SONM
  • PMCB
  • Analyst Count
  • SONM 0
  • PMCB 0
  • Target Price
  • SONM N/A
  • PMCB N/A
  • AVG Volume (30 Days)
  • SONM 20.4K
  • PMCB 37.2K
  • Earning Date
  • SONM 11-12-2024
  • PMCB 09-17-2024
  • Dividend Yield
  • SONM N/A
  • PMCB N/A
  • EPS Growth
  • SONM N/A
  • PMCB N/A
  • EPS
  • SONM N/A
  • PMCB 0.54
  • Revenue
  • SONM $69,288,000.00
  • PMCB N/A
  • Revenue This Year
  • SONM N/A
  • PMCB N/A
  • Revenue Next Year
  • SONM $107.78
  • PMCB N/A
  • P/E Ratio
  • SONM N/A
  • PMCB $3.33
  • Revenue Growth
  • SONM N/A
  • PMCB N/A
  • 52 Week Low
  • SONM $2.32
  • PMCB $1.39
  • 52 Week High
  • SONM $10.70
  • PMCB $2.58
  • Technical
  • Relative Strength Index (RSI)
  • SONM 47.26
  • PMCB 50.51
  • Support Level
  • SONM $2.67
  • PMCB $1.72
  • Resistance Level
  • SONM $3.11
  • PMCB $2.06
  • Average True Range (ATR)
  • SONM 0.26
  • PMCB 0.28
  • MACD
  • SONM 0.03
  • PMCB 0.00
  • Stochastic Oscillator
  • SONM 18.48
  • PMCB 44.12

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: